Esoferr Indications/Uses

DR cap: Esomeprazole delayed-release capsule is indicated for: Gastroesophageal Reflux Disease (GERD): treatment of erosive reflux esophagitis.
Long-term management of patients with healed esophagitis to prevent relapse.
Symptomatic treatment of gastroesophageal reflux disease (GERD).
In combination with an appropriate antibacterial therapeutic regimen for the eradication of Helicobacter pylori: healing of Helicobacter pylori associated duodenal ulcer.
Patients requiring continued NSAID therapy: healing of gastric ulcers associated with NSAID therapy.
Prevention of gastric and duodenal ulcers associated with continuous NSAID therapy in patient at risk. Patients are considered to be at risk due to their age (>60 years) and documented history of peptic ulcer. Available clinical controlled study do not extend beyond 6 months.
Treatment of Zollinger-Ellison syndrome.
Powd for inj: Esomeprazole injection is indicated for: Gastric antisecretory treatment when the oral route is not possible, such as: Gastro esophageal reflux disease in patients with esophagitis and/or severe symptoms of reflux.
Healing of gastric ulcers associated with NSAIDs therapy.
The short term maintenance of hemostasis and prevention of rebleeding in patients following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.